FORMULATION AND CHARACTERIZATION OF MATRIX AND TRIPLE-LAYER MATRIX TABLETS FOR CONTROLLED DELIVERY OF METOPROLOL TARTRATE

Authors

  • Izhar Ahmed Syed Department of Pharmaceutics, Jayamukhi College of Pharmacy, Warangal-506332, Andhra Pradesh, India
  • Lakshmi Narsu Mangamoori Centre for Biotechnology, IST, JNT University, Hyderabad-85, Andhra Pradesh, India
  • Yamsani Madhusudan Rao University College of Pharmaceutical Sciences, Kakatiya University, Warangal-506009, Andhra Pradesh, India

Abstract

In the present study matrix and triple layer matrix tablets of metoprolol tartrate were formulated by using xanthan gum as the matrix forming agent and Sodium Carboxy Methyl Cellulose (Na CMC) as barrier layers. The prepared tablets were analysed for their hardness, friability, drug content and in-vitro drug release studies. Marked differences in dissolution characteristics of (M3) and (M3L3) were observed and showed a significant difference statistically. Mean dissolution time (MDT) for M3 and M3L3 were found to be 4.02h and 12.75h, while dissolution efficiency (DE8%) decreased, indicating that the release of metoprolol tartrate is slower from triple layer matrix tablets. The finding of the study indicated that the matrix tablets prolonged the release, but predominantly in a first order kinetics. Layering with Na CMC granules on the matrix core, provided linear drug release with zero order kinetics. The triple layer matrix tablets (M3L3) shows precise controlled release of the drug than that of plain matrix tablets. FT-IR and DSC studies confirmed that there was no chemical interaction between drug and excipients used in the formulation.

Keywords:

Metoprolol tartrate, Controlled release, linear drug release, Zero order kinetics.

DOI

https://doi.org/10.25004/IJPSDR.2011.030105

References

Colombo P, Conte U, Gazzaniga A, Maggi L, Sangalli M. E, Peppas N. Drug release modulation by physical restrictions of matrix swelling. Int J Pharm. 1990; 63: 43-48.

Conte U, Maggi L, Colombo P, La Manna A. Multi-layered hydrophilic matrices as constant release devices. J Control Rel. 1993; 26: 39-47.

Yihong Qui, Chidambaram N, Kolette F. Design and evaluation of layered diffusional matrices for zero order sustained-release tablets. J Control Rel. 1998; 51: 123-130.

Conte U, Maggi L. Modulation from Geomatrix® multi-layer matrix tablets containing drugs of different solubility. Biomaterials.1996; 17 (9): 889-896.

Yihong Qui, Kolette F. Design of sustained release matrix system for a highly water soluble compound ABT-089. Int J Pharm. 1997; 157: 46-52

Krishnaiah YSR, Karthikeyan S, Gouri VS, Satyanarayana V. Three-layer guar gum matrix tablet formulations for oral controlled delivery of highly soluble trimetazidine dihydrochloride. J Control Rel. 2002; 81: 45-56.

Yeole PG, Galgatte UC, Babla IB, Nakhat PD. Design and evaluation of Xanthan gum-based sustained release Matrix tablets of Diclofenac sodium. Indian Journal Pharmaceutical Sciences. 2006; 68:185-189.

Tobyn MJ, Stani forth JN, Baichwal AR, Mc Call TW. Prediction of physical properties of a novel polysaccharide controlled release system. Int J Pharm. 1996; 128: 113-22.

Talukdar MM, Mooter VD, Augustijns P, Maga TT, Verbeke N, Kinget R. In vitro evaluation of xanthan gum as potential excipients for oral controlled release matrix tablet formulation. Int J Pharm. 1998; 169: 105-13.

Talukdar MM, Vercammen JP. Evaluation of xanthan gum as a hydrophillic matrix for controlled release dosage forms. Drug Dev Ind Pharm. 1993; 19:1037-46.

Talukdar MM, Mooter VD, Augustijns P, Maga TT, Verbeke N, Kinget R. In vitro evaluation of xanthan gum as potential excipients for oral controlled release matrix tablet formulation. Int J Pharm. 2000; 169: 105-113.

Regardh CG, Borg KO, Johnsson R, Johnsson G, Palmer L. Pharmacokinetic studies on the selective ß1-receptor antagonist metoprolol in man. J Pharmacokinet Biopharm. 1974; 2: 347-364.

Varshosaz J, Tavakoli N, Eram SA Use of Natural Gums and Cellulose Derivatives in Production of Sustained Release Metoprolol Tablets. Drug Delivery. 2006; 13:113-119.

Gohel MC, Panchal MK. Novel use of similarity factors f2 and Sd for the development of diltiazem HCl modified-release tablets using a 3(2) factorial design. Drug Dev Ind Pharm. 2002; 28(1): 77-87.

Banakar UV. Pharmaceutical Dissolution Testing, 1st ed. New York: Marcel Dekker Inc, 1999, pp 191-194.

Mathews BR, Regulatory aspects of stability testing in Europe. Drug Dev Ind Pharm. 1999; 25: 831-856.

Published

01-01-2011
Statistics
Abstract Display: 291
PDF Downloads: 376
Dimension Badge

How to Cite

“FORMULATION AND CHARACTERIZATION OF MATRIX AND TRIPLE-LAYER MATRIX TABLETS FOR CONTROLLED DELIVERY OF METOPROLOL TARTRATE”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 3, no. 1, Jan. 2011, pp. 23-28, https://doi.org/10.25004/IJPSDR.2011.030105.

Issue

Section

Research Article

How to Cite

“FORMULATION AND CHARACTERIZATION OF MATRIX AND TRIPLE-LAYER MATRIX TABLETS FOR CONTROLLED DELIVERY OF METOPROLOL TARTRATE”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 3, no. 1, Jan. 2011, pp. 23-28, https://doi.org/10.25004/IJPSDR.2011.030105.